ClinicalTrials.Veeva

Menu

A Retrospective Study to Collect the Data From the Patients Who Had the Perimount Heart Valve Replacement Surgery in China During 2001 to 2007

Edwards Lifesciences logo

Edwards Lifesciences

Status

Completed

Conditions

Mitral Valve or Aortic Valve Replacement

Treatments

Device: Perimount 2900/6900 Heart Valve

Study type

Observational

Funder types

Industry

Identifiers

NCT02381678
Edwards-CN-001

Details and patient eligibility

About

The objective of the study is to obtain the clinical data from patients who had the Perimount Heat Valve (Type:6900P and 2900) Replacement Surgery in Guangdong General Hospital during 2001-2007 in order to evaluate the performace of this heart valve prothesis and collect the patients' post-operation infomation including the current living status, mortality rate, and the possibility of re-operation,bleeding and thrombosis.

This is a retrospective , observentional clinical study to be conducted in Guangdong General Hospital in China. This study will enroll up to 200 patients.

Enrollment

225 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients who implanted with Perimount Heart Valve (Type: 6900P and 2900) during 2001-2007 in Guangdong General Hospital in China
  • The patients agree to join the study and sign the ICF

Exclusion criteria

  • No specific exclusion criteria

Trial design

225 participants in 1 patient group

Subjects implanted with Perimount Heart Valve
Description:
Only one group was set for this study, including all enrolled subjects who implanted with Perimount Heart Valve during 2001 to 2007
Treatment:
Device: Perimount 2900/6900 Heart Valve

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems